A detailed history of Rock Springs Capital Management LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 151,000 shares of BMRN stock, worth $9.58 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
151,000
Previous 151,000 -0.0%
Holding current value
$9.58 Million
Previous $12.4 Million 14.62%
% of portfolio
0.36%
Previous 0.39%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $161,364 - $199,932
2,168 Added 1.46%
151,000 $12.4 Million
Q4 2023

Feb 14, 2024

SELL
$76.22 - $98.51 $8.82 Million - $11.4 Million
-115,668 Reduced 43.73%
148,832 $14.4 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $37,140 - $46,345
500 Added 0.19%
264,500 $20.4 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $753,060 - $960,435
10,500 Added 4.14%
264,000 $23.3 Million
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $7.01 Million - $8.7 Million
-96,500 Reduced 27.57%
253,500 $22.2 Million
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $2.7 Million - $4.91 Million
-37,500 Reduced 9.68%
350,000 $26.6 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $596,625 - $931,650
7,500 Added 1.97%
387,500 $47.8 Million
Q1 2020

May 15, 2020

BUY
$71.37 - $96.85 $3.03 Million - $4.12 Million
42,500 Added 12.59%
380,000 $32.1 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $12.5 Million - $16.8 Million
195,000 Added 136.84%
337,500 $28.5 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $602,625 - $704,250
7,500 Added 5.56%
142,500 $12.2 Million
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $505,200 - $591,720
6,000 Added 4.65%
135,000 $12 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $320,560 - $424,280
4,000 Added 3.2%
129,000 $11 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $10.1 Million - $11.9 Million
125,000
125,000 $11.6 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.